Infusion-related reactions with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: f62e8165aede193b29660b1a9462ce4c92b55667
First added on: Apr 29, 2026